QCG
ANIK icon

Quadrant Capital Group’s Anika Therapeutics ANIK Stock Holding History

Quadrant Capital Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-326
Closed -$8.05K – 2737
2024
Q3 		$8.05K Hold
326
– – ﹤0.01% 2204
2024
Q2 		$8.26K Sell
326
-190
-37% -$4.92K ﹤0.01% 2177
2024
Q1 		$13.1K Buy
516
+190
+58% +$4.6K ﹤0.01% 2003
2023
Q4 		$7.39K Buy
326
+270
+482% +$5.59K ﹤0.01% 2168
2023
Q3 		$1.04K Sell
56
-1,148
-95% -$23.8K ﹤0.01% 2483
2023
Q2 		$31.3K Buy
1,204
+40
+3% +$1.07K ﹤0.01% 1486
2023
Q1 		$33.4K Buy
1,164
+12
+1% +$357 ﹤0.01% 1448
2022
Q4 		$34.1K Buy
1,152
+80
+7% +$2.28K ﹤0.01% 1396
2022
Q3 		$26K Buy
1,072
+1,043
+3,597% +$24K ﹤0.01% 1400
2022
Q2 		$1K Buy
+29
New +$647 ﹤0.01% 2315
2018
Q4 		– Sell
-20
Closed – – 2195
2018
Q3 		$0 Hold
20
– – ﹤0.01% 2130
2018
Q2 		$0 Hold
20
– – ﹤0.01% 2146
2018
Q1 		$0 Hold
20
– – ﹤0.01% 2157
2017
Q4 		$1K Hold
20
– – ﹤0.01% 1912
2017
Q3 		$1K Hold
20
– – ﹤0.01% 1921
2017
Q2 		$0 Hold
20
– – ﹤0.01% 1854
2017
Q1 		$0 Hold
20
– – ﹤0.01% 2060
2016
Q4 		$0 Hold
20
– – ﹤0.01% 1990
2016
Q3 		$0 Hold
20
– – ﹤0.01% 1991
2016
Q2 		$1K Hold
20
– – ﹤0.01% 1572
2016
Q1 		$0 Buy
+20
New +$811 ﹤0.01% 1801

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Quadrant Capital Group's ANIK Position: Q4 2024 in Review

Quadrant Capital Group sold out of Anika Therapeutics (ANIK) in Q4 2024, closing a stake of 326 shares — an estimated $8.05K sold.

Quadrant Capital Group first reported a position in ANIK in Q1 2016 and held it in 21 quarters. The position peaked at $34.1K in Q4 2022. 109 funds tracked by Wall St. Rank hold ANIK as of Q4 2024.

  • Quadrant Capital Group reported no remaining Anika Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 326 Anika Therapeutics shares in Q4 2024, an estimated $8.05K.
  • Quadrant Capital Group first reported a position in Anika Therapeutics in Q1 2016 and held it in 21 quarters.
  • Quadrant Capital Group's Anika Therapeutics position peaked at $34.1K in Q4 2022.
  • 109 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2024.

Based on Quadrant Capital Group's 13F filing for Q4 2024, filed 13 Feb 2025.